The company concentrates on research and development in the areas of medicine and biotechnologies. The company has implemented more than 20 projects resulted in developing, licensing and launching advanced diagnostic products and technologies in the fields of laboratory diagnostics, genetics and personalized medicine. MBU-Technology LLC is currently
- providing services to the enterprises interested in molecular-genetic testing, conducting research by PCR and polarization fluoroimmunoassay methods, lyophilization, and chromatographic purification;
- developing and producing reagent kits for in vitro diagnostics, including various recombinant proteins, conjugates, stabilized cells and other components used for diagnostic reagent kit production;
- designing high-tech medical devices.
Molecular-genetic testing is carried out at the company’s own clinical diagnostic laboratory
(License № ЛО-54-01-004357 issued on 12.05.2017).
MBU-Technology LLC is a resident of the Technopark in Novosibirsk Academgorodok, a member of the Innovational territorial cluster of information and biopharmaceutical technologies in the Novosibirsk Region.